Ensysce Biosciences, Inc.
Ticker: 1716947
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.96+95.9% | 0.49-64.2% | 1.37+3.8% | 1.32-61.4% | 3.42+1800.0% | 0.18-41.9% | 0.31-29.5% | 0.44 |
| Total Income | 0.96+95.9% | 0.49-64.2% | 1.37+3.8% | 1.32-61.4% | 3.42+1800.0% | 0.18-41.9% | 0.31-29.5% | 0.44 |
| EXPENSES | ||||||||
| Expenditure | 4.52+6.9% | 4.23+35.6% | 3.12-5.2% | 3.29+18.8% | 2.77+29.4% | 2.14-0.5% | 2.15-31.5% | 3.14 |
| PROFIT | ||||||||
| Net Profit | -3.56+4.6% | -3.73-115.6% | -1.73+11.3% | -1.95-395.5% | 0.66+133.5% | -1.97+36.9% | -3.12-16.0% | -2.69 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00%-118.86pp | 18.86%+118.86pp | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00%-119.35pp | 19.36%+119.35pp | -100.00% | -100.00% | -100.00% |
| EPS | -0.52+59.7% | -1.29-63.3% | -0.79+43.2% | -1.39-2085.7% | 0.07+131.8% | -0.22+60.0% | -0.55+36.8% | -0.87 |
Corporate Events
Board MeetingENSC
202610Jul
Board Meeting
Jeffrey Millard resigned as Chief Operating Officer of Ensys…
SEC Filing ↗ Board MeetingENSC
20261Apr
Board Meeting
Director Resignation — Curtis Rosebraugh resigned from the B…
SEC Filing ↗